AN INNOVATIVE
PHARMACEUTICAL COMPANY WITH
GROUNDBREAKING PATENTS
A Natural and Innovative Remedy for Animals - CoxyPet®
There are more than 1.5 billion cattle, 960 million pigs, 600 million horses, 900 million dogs, and 600 million cats worldwide.
The use of acetylsalicylic acid orally or by injection in veterinary medicine is strongly discouraged in many countries and is prohibited in some, including the United States and the United Kingdom.
Livestock, including cows and pigs, are regularly treated with antibiotics as a preventive measure, leading to significant losses in milk and meat production during treatment.
Reduce the Use of Antibiotics
CoxyPet® offers natural and innovative solutions for animal medication. Skin pain can be treated with CoxyPet®, not only to relieve pain and reduce inflammation but also to improve animal welfare.
The use of CoxyPet® through local application can reduce reliance on antibiotics and other medications, thereby helping to decrease antibiotic resistance and minimize climate and environmental impact.
Great Potential with Multiple Benefits
CoxyPet® will be based on groundbreaking research in veterinary medicine and contains several substances with curative effects. CoxyPet® will stand out by allowing animal caretakers to apply the treatment themselves, without any risk of overdosing – making it both safe and effective.
This innovation represents a significant advancement in modern animal care and opens new opportunities to improve animal health in a sustainable way.
